Oscar Health, Inc. — Form 8-K
Filed August 6, 2026 · analyzed by the 8-K Agent
8-K
▲ Likely positive
significance 72/100
What the filing says
Oscar Health reported H1 2026 net income of $1.04B ($3.16 diluted EPS) versus $47M ($0.17) in H1 2025, on revenue of $9.53B versus $5.91B. The company raised full-year 2026 operating earnings guidance from $250–450M to $500–700M, improved MLR from 83.0% to 75.0% (H1 YoY), and maintained revenue guidance of $18.7–19.0B. Membership grew to 2.96M (Individual/Small Group) from 2.02M YoY. CEO cited disciplined pricing, improved underwriting, and $164M favorable prior-period reserve development.
Why this rating
Strong profitability swing and doubled earnings guidance is material—represents ~11–16% of company market cap in annualized operating income. Meaningful relative to ~$4.5B market cap; demonstrates operational execution. Not transformational (no M&A/bankruptcy) but substantial guidance raise justifies 60–84 band.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.